
Geschlossen
Veröffentlicht
Bezahlt bei Lieferung
M&A Deal Analysis Presentation (Sun Pharma / Ranbaxy / Daichi Sankyo) Project Overview I am looking for a finance expert or investment banking analyst to create a comprehensive, high-quality PowerPoint presentation (15-20 slides) analyzing the multi-stage merger and acquisition deal involving Daichi Sankyo, Ranbaxy, and Sun Pharma (2008 and 2014). This is an academic project for an Executive MBA course. The final output must be professional, data-driven, and visually engaging. Key Deliverables • Slide Count: 15–20 slides. • Content: Detailed analysis covering two phases: Daichi Sankyo's 2008 acquisition of Ranbaxy and Sun Pharma's 2014 acquisition of Ranbaxy. • Narrative: The presentation must tell a "story" of the deal, including a clear timeline of key events. • Accuracy: All financial data must be 100% accurate and hyperlinked to authentic sources (Annual reports, financial statements, etc.). Detailed Requirements The analysis must cover the following points specifically: 1. Firm Profiles: Background, products, markets, and management of all involved firms. 2. Strategic Intent: The "Why" behind both deals. 3. Deal Mechanics: Friendly vs. Hostile nature, source of financing, and swap ratios. 4. Valuation: Investment bankers involved, valuation methods used (DCF, Multiples), and deal premium paid. 5. Integration & Challenges: Post-integration plans, management changes, and the regulatory/legal hurdles faced by Ranbaxy. 6. Synergies: Analysis of operating, financial, and marketing synergies. 7. Financial Impact: Evaluation of whether the deal created value based on financial statements. Requirements for the Freelancer • Strong background in Corporate Finance, M&A, or Investment Banking. • Expertise in creating professional PPTs with infographics and charts. • Ability to source and cite official financial documents (SEC filings, RERA, Annual Reports). • Strict Deadline: The project must be completed by December 26th (to allow for a review before the final submission on the 27th).
Projekt-ID: 40086318
3 Vorschläge
Remote Projekt
Aktiv vor 21 Tagen
Legen Sie Ihr Budget und Ihren Zeitrahmen fest
Für Ihre Arbeit bezahlt werden
Skizzieren Sie Ihren Vorschlag
Sie können sich kostenlos anmelden und auf Aufträge bieten
3 Freelancer bieten im Durchschnitt ₹601 INR für diesen Auftrag

Hi, I can deliver a professional, investment-banking–style M&A analysis deck on the Daichi Sankyo–Ranbaxy–Sun Pharma transactions (2008 & 2014) that is accurate, data-driven, and suitable for an Executive MBA submission. I’ll build a 15–20 slide PowerPoint with a clear narrative arc and timeline covering both deal phases—why each acquirer acted, how the transactions were structured, and what value was ultimately created or destroyed. The analysis will include firm profiles, strategic intent, deal mechanics (friendly/hostile, financing, swap ratios), valuation approaches (DCF, trading/transaction multiples, premiums), integration challenges, regulatory issues, synergies, and post-deal financial impact. All financial figures will be 100% accurate and hyperlinked to authentic sources (annual reports, filings, investor presentations). Charts, tables, and infographics will be used where they strengthen clarity, without diluting academic rigor. My background in corporate finance and M&A analysis, combined with Chartered Accountancy articleship experience, ensures defensible assumptions, clean valuation logic, and boardroom-grade presentation quality. I’m comfortable with tight deadlines and can complete the deck by December 26, leaving room for your review before final submission. I can also share samples of similar M&A / transaction analysis presentations on request. Best regards, Akram
₹600 INR in 3 Tagen
2,6
2,6

You will get the best presentation within best time as well as maintaining high quality and structure.
₹601 INR in 2 Tagen
0,0
0,0

I would be excited to work on your Executive MBA–level M&A Deal Analysis covering the Daiichi Sankyo–Ranbaxy (2008) and Sun Pharma–Ranbaxy (2014) transactions. This is one of the most widely cited and complex pharmaceutical M&A case studies in emerging markets, and I have the corporate finance, valuation, and presentation expertise required to deliver a rigorous, top-grade output.
₹601 INR in 7 Tagen
0,0
0,0

New Delhi, India
Mitglied seit Dez. 18, 2024
₹1500-12500 INR
₹600-1500 INR
$250-750 USD
₹600-700 INR
$30-250 USD
₹12500-37500 INR
$250-750 USD
min. ₹2500 INR / Stunde
£750-1500 GBP
₹12500-37500 INR
₹12500-37500 INR
₹12500-37500 INR
$30-250 USD
$30-250 USD
$30-250 USD
$30-250 USD
£2-5 GBP / Stunde
₹400-750 INR / Stunde
$10-30 AUD
$10000-20000 USD
$750-1500 USD
$5-250 USD / Stunde